25th Feb 2026 TASUKI-52 study of combination therapy using nivolumab, platinum chemotherapy, and bevacizumab for advanced or recurrent nonsquamous NSCLC: a plain language summary
17th Dec 2021 Comparing EGFR tyrosine kinase inhibitor treatments in EGFR-mutated non-small cell lung cancer across Asian and non-Asian patients: a plain language summary
